Business Wire

ResMed Introduces AirFit N30, World’s First Tube-Down Nasal Cradle CPAP Mask

Share

ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea treatment.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191021005138/en/

ResMed AirFit N30, tube-down nasal cradle CPAP mask (Photo: Business Wire)

ResMed AirFit N30, tube-down nasal cradle CPAP mask (Photo: Business Wire)

ResMed’s lightest mask yet, AirFit N30 features an adjustable elastic headgear, plus a nasal cradle cushion that sits under the nasal bridge, eliminating soreness in that area. The mask’s curved cushion is designed to provide a secure seal regardless of how the wearer sleeps or moves.

Together, these innovations help make starting and staying on CPAP therapy easier than ever for more of the 936 million people worldwide living with sleep apnea.

“AirFit N30 is about ease of use, helping people ease into therapy and addressing the most common pain points for longtime users,” said Jim Hollingshead, president of ResMed’s Sleep business. “As the first mask of its kind, AirFit N30 reflects ResMed’s continued leadership in sleep innovation – the cornerstone of our company for over 30 years.”

AirFit N30 joins ResMed’s award-winning portfolio of Minimalist CPAP masks designed to be small, light, and easy to use, including the popular AirFit P10 nasal pillows mask and AirFit F30 minimal-contact full-face mask.

AirFit N30 is now available in the United States, with other countries to follow.

About ResMed

At ResMed (NYSE: RMD) (ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 120 countries. To learn more, visit ResMed.com and follow @ResMed.

Contact information

For media
Jayme Rubenstein
+1 858.836.6798
news@resmed.com

For investors
Amy Wakeham
+1 858.836.5000
investorrelations@resmed.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CHTF2019 Kicks off in Shenzhen, Gathering Global Exhibitors and Visitors13.11.2019 15:48:00 EETPress release

China’s No. 1 technology show – the 21st China Hi-Tech Fair (CHTF2019) – opened at the Shenzhen Convention and Exhibition Center on November 13, and will run till November 17. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005440/en/ Themed on "Invigorating the Greater Bay Area through Opening-up and Innovation," CHTF2019 is expected to attract more than 3,300 exhibitors from home and abroad, as well as over 500,000 visitors coming from over 100 countries and regions. This year, CHTF arranged 5 key routes for visitors: The Greater Bay route, 5G route, smart manufacturing route, gadget route and the investment potential route. The event will cover every sector of the hi-tech industry including artificial intelligence, smart home, smart manufacturing, Internet of Things, smart driving, 5G, folding screen mobile phones, etc. CHTF2019 will witness an increased number and diversity of exhibitors. 44 countries and internatio

ADVA unveils commercially ready disaggregated cell site gateway solution at TIP ’1913.11.2019 15:15:00 EETPress release

ADVA (FSE: ADV) today announced the commercial readiness of its disaggregated cell site gateway (DCSG) solution at the Telecom Infra Project (TIP) Summit. Powered by ADVA’s Ensemble Activator network operating system (NOS), the integrated white box solution comes with a comprehensive bundle of installation, commissioning and monitoring services for rapid network deployment. The technology is currently on display in a 5G demo at the TIP Summit with ADVA’s software running on Edgecore’s new family of DCSG devices. The showcase highlights how mobile network operators (MNOs) now have an easy and cost-effective route to mass small cell deployment for 5G services. Already successful in a series of trials in global MNO networks, Ensemble Activator is the industry’s only true carrier-grade NOS for bare-metal switches. “This is a landmark moment for mobile networks. Now that MNOs can leverage our DCSG solution as a simple and complete answer for evolving their infrastructure to 5G, the shackles

Visa Introduces Team Visa Roster Ahead of the Olympic and Paralympic Games Tokyo 202013.11.2019 15:00:00 EETPress release

Visa (NYSE: V), the Worldwide Payment Technology Partner of the Olympic and Paralympic Games, today announced its most diverse roster of athletes on Team Visa Tokyo 2020. Representing 43 countries, the most in Team Visa history, the current roster is comprised of 70+ athletes across 30+ sports, including new additions to The Games: Surfing, Skateboarding and Sport Climbing. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191113005219/en/ Visa Introduces Team Visa Roster Ahead of the Olympic and Paralympic Games Tokyo 2020 (Graphic: Business Wire) The announcement was made at the Team Visa Summit, hosted at the company’s San Francisco Innovation Center. The Summit offers athletes resources on how to improve financial literacy, benefit from digital payments and elevate their personal brand. “As one of the longest standing partners of the Olympic and Paralympic Games, Visa looks forward to Tokyo 2020. Set to be the largest Games

Vertex Confirms Wales Offer Accepted for Access to All Licensed Cystic Fibrosis Medicines13.11.2019 14:29:00 EETPress release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today confirms that NHS Wales has accepted an offer for all currently licensed Vertex cystic fibrosis (CF) medicines and any future indications of these medicines under the same terms as the recently announced agreement with NHS England. This means that once the contract is finalized, patients with CF in Wales ages 2 years and older who have two copies of the F508del mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene can access ORKAMBI ® (lumacaftor/ivacaftor) and CF patients ages 12 years and older who either have two copies of the F508del mutation or one copy of the F508del mutation and a copy of one of the other 14 licensed mutations can access SYMKEVI® (tezacaftor/ivacaftor) in combination with ivacaftor in the coming weeks. The agreement also offers expanded access to KALYDECO ® (ivacaftor) to include those patients ages 12 months and older who have one of the nine licensed gating mutations. “Today’s a

Software Testing and Digital Transformation Partners Recognized at 2019 Tricentis Partner Awards13.11.2019 14:00:00 EETPress release

Tricentis, the cloud’s #1 Continuous Testing Platform, today recognized top-performing partners from around the world during Tricentis Accelerate 2019 in Vienna, Austria. In its 5th year, the Tricentis Partner Awards recognize organizations for accelerating digital transformation across the enterprise. Award winners were selected from more than 300 different partners worldwide based on their collaboration with Tricentis, customers, and their advocacy for Tricentis’ automation methodologies. “Tricentis partners are leading the way for organizations to innovate faster, reduce business risk, and optimize cost,” said Alan Ota, Senior Vice President of Strategic Alliances, Tricentis. “Our partners are instrumental to our business and are focused on delivering the best in-class testing solutions to our joint customers. Our tremendous growth would not be possible without our global partners. We’re proud to acknowledge the achievements made by our partners in 2019 and look forward to continuin

Applicaster Appoints Jason Johns as Vice President of Sales, EMEA and APAC13.11.2019 13:00:00 EETPress release

Applicaster, the company simplifying the lifecycle management of direct-to-consumer media applications, today announced the appointment of Jason Johns as Vice President of Sales, EMEA and APAC. In his role, Johns will oversee Applicaster’s EMEA and APAC commercial and go-to-market strategies. “There is an incredible amount of opportunity in the media app market,” said Johns. “Because of our ability to enable frictionless growth for customers, we’re very well positioned to take advantage of this opportunity. Beyond the market opportunity, I was attracted to Applicaster because of the company’s customer-first culture plus its ability and desire to drive value lead engagements. Few businesses buy technology without a clear understanding of the business case and full transparency of the cost-of-ownership around their technology investments - Applicaster understands this and provides flexible commercial models that scale and can easily be upgraded and expanded as business requirements evolv

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom